arginine has been researched along with Carcinoma, Lobular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexandre, CO; Damin, AP; Damin, DC; Frazzon, AP; Hermes, V; Roehe, A; Zettler, C | 1 |
Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG | 1 |
1 trial(s) available for arginine and Carcinoma, Lobular
Article | Year |
---|---|
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine | 1998 |
1 other study(ies) available for arginine and Carcinoma, Lobular
Article | Year |
---|---|
Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Arginine; Brazil; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Risk Factors | 2006 |